详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Protein SUMOylation modification and its associations with disease.

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, No.17, 3rd Section of People’s South Road, Chengdu, 610041, People’s Republic of China [2]Department of Urinary Surgery, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, People’s Republic of China [3]Laboratory of Cell and Molecular Biology & State Key Laboratory of Molecular Oncology, Cancer Institute & Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, 100034, People’s Republic of China

出处：

DOI：

关键词： SUMOylation SUMO pathway deSUMOylation disease

摘要：

SUMOylation, as a post-translational modification, plays essential roles in various biological functions including cell growth, migration, cellular responses to stress and tumorigenesis. The imbalance of SUMOylation and deSUMOylation has been associated with the occurrence and progression of various diseases. Herein, we summarize and discuss the signal crosstalk between SUMOylation and ubiquitination of proteins, protein SUMOylation relations with several diseases, and the identification approaches for SUMOylation site. With the continuous development of bioinformatics and mass spectrometry, several accurate and high-throughput methods have been implemented to explore small ubiquitin-like modifier-modified substrates and sites, which is helpful for deciphering protein SUMOylation-mediated molecular mechanisms of disease. © 2017 The Authors.

基金：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2017]版：

大类 | 2 区生物

小类 | 2 区生化与分子生物学

最新[2023]版：

大类 | 3 区生物学

小类 | 3 区生化与分子生物学

第一作者：

第一作者机构： [1]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, No.17, 3rd Section of People’s South Road, Chengdu, 610041, People’s Republic of China

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Protein SUMOylation modification and its associations with disease. [2]MS-based strategies for identification of protein SUMOylation modification. [3]SUMOylation of IQGAP1 promotes the development of colorectal cancer. [4]Small-Molecule Inhibitors Targeting Protein SUMOylation as Novel Anticancer Compounds. [5]SAE1 promotes human glioma progression through activating AKT SUMOylation-mediated signaling pathways [6]SUMOylation of IQGAP1 promotes the development of colorectal cancer. [7]Association of chronic obstructive pulmonary disease with coronary artery disease [8]SUMO2/3 promotes the progression and oxaliplatin resistance of colorectal cancer through facilitating the SUMOylation at Ku80-K307 [9]Prominent gallbladder enlargement: Kawasaki disease or other congenital or acquired gallbladder disease? A case report [10]Ferroptosis in health and disease